Celcuity Inc. (CELC): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2019-12-31, 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$249.0K
Year ended 2025-12-31
$450.0K
Trailing 12 months to 2026-06-30
+16.2%
3-year compound annual growth
+22.7%
5-year compound annual growth
$629.6K2016-12-31: $40.9K2017-12-31: $239.8K2018-12-31: $629.6K2019-12-31: -$380.2K2020-12-31: $89.4K2021-12-31: $81.9K2022-12-31: $158.8K2023-12-31: $97.6K2024-12-31: $250.0K2025-12-31: $249.0K$249.0K
2016-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$249.0K-0.4%2026-03-26, From 2025-01-01
2024-12-31$250.0K+156.0%2026-03-26, From 2024-01-01
2023-12-31$97.6K-38.5%2025-03-31, From 2023-01-01
2022-12-31$158.8K+93.9%2024-03-27, From 2022-01-01
2021-12-31$81.9K-8.4%2023-03-23, From 2021-01-01
2020-12-31$89.4Kn/c2022-03-23, From 2020-01-01
2019-12-31-$380.2Kn/c2021-02-16, From 2019-01-01
2018-12-31$629.6K+162.5%2020-03-13, From 2018-01-01
2017-12-31$239.8K+486.4%2019-03-01, From 2017-01-01
2016-12-31$40.9Kn/a2018-03-15, From 2016-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Celcuity Inc. (CELC)2025-12-31$249.0K-0.4%
Castle Biosciences Inc (CSTL)2025-12-31$36.02M+27.2%
BillionToOne, Inc. (BLLN)2025-12-31$8.88M+64.4%
Personalis, Inc. (PSNL)2025-12-31$4.50M+181.0%
Caris Life Sciences, Inc. (CAI)2025-12-31$16.26M+92.6%
Fulgent Genetics, Inc. (FLGT)2025-12-31$22.57M-44.0%
Veracyte, Inc. (VCYT)2025-12-31$9.68M-14.3%
Guardant Health, Inc. (GH)2025-12-31$48.31M+37.7%
Sera Prognostics, Inc. (SERA)2025-12-31$726.0Kn/m

Compare CELC, CSTL, BLLN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗